This week the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced the list of 41 drugs available through Medicare Part B that will have a lowered Part B coinsurance rate from April … [Read more...] about Medicare Drug Pricing Updates from HHS
Medicare Part D / Prescription Drugs
Good Progress in Litigation Against Medicare Drug Price Negotiations
In nine lawsuits filed across the country, the pharmaceutical industry is challenging the Medicare drug price negotiation program established by the Inflation Reduction Act (IRA). So far, the drug companies have not scored any victories, which means … [Read more...] about Good Progress in Litigation Against Medicare Drug Price Negotiations
Implementation of Medicare Drug Law Proceeds
Drug Industry Continues to Fight It; President Biden Proposes to Expand ItThe Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2022, has already provided cost-savings for Medicare beneficiaries through … [Read more...] about Implementation of Medicare Drug Law Proceeds
Center for Medicare Advocacy Submits Comment on Proposed 2025 Medicare Advantage and Part D Rule
On January 5, 2024, the Center submitted comments to a proposed rule for Medicare Advantage (MA) and Part D issued by the Centers for Medicare & Medicaid Services (CMS) titled: Medicare Program; Contract Year 2025 Policy and Technical Changes to … [Read more...] about Center for Medicare Advocacy Submits Comment on Proposed 2025 Medicare Advantage and Part D Rule
New Medicare Drug Provisions Now in Effect – Including Out-of-Pocket Changes
The Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2022, has already provided cost-savings for Medicare beneficiaries through provisions that took effect last year in 2023, including a monthly cap of $35 for … [Read more...] about New Medicare Drug Provisions Now in Effect – Including Out-of-Pocket Changes
Center Joins Fight Against Drug Manufacturer Seeking to End Medicare Price Negotiations
This week, the Center for Medicare Advocacy joined a coalition of advocates led by AARP that is urging a federal court to reject an attempt to block Medicare’s drug price negotiation program. The case is one of many brought by drug manufacturers … [Read more...] about Center Joins Fight Against Drug Manufacturer Seeking to End Medicare Price Negotiations
More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
The Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2023, is already providing cost-savings for Medicare beneficiaries in 2023, including a monthly cap of $35 for covered insulin and free vaccines for certain … [Read more...] about More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
Medicare Drug Price Negotiation Program Begins After Encouraging Court Decision
A federal court has rejected a bid by the pharmaceutical industry and its allies to stop the newly established Medicare drug price negotiation program before it starts. On September 29, 2023, Judge Michael J. Newman of the U.S. District Court for … [Read more...] about Medicare Drug Price Negotiation Program Begins After Encouraging Court Decision
CMS Releases Notices Regarding LIS
The Centers for Medicare & Medicaid Services (CMS) notified Medicare Advantage organizations and Part D Plans that it will conduct reassignment this month of beneficiaries eligible for the Part D Low-Income Subsidy (LIS) who are enrolled in … [Read more...] about CMS Releases Notices Regarding LIS
One-Year Anniversary of Medicare Prescription Drug Law: Beneficiaries Already Saving Money but Drug Industry Fights Progress
August 16, 2023 marked the one-year anniversary of the Inflation Reduction Act of 2022 (IRA) being signed into law by President Biden. As outlined in a previous CMA Alert (March 2, 2023), the IRA law includes historic prescription drug provisions … [Read more...] about One-Year Anniversary of Medicare Prescription Drug Law: Beneficiaries Already Saving Money but Drug Industry Fights Progress